diazoxide has been researched along with Cardiac Remodeling, Ventricular in 2 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Angiotensin II (Ang II) and tumour necrosis factor alpha (TNFalpha) are involved in the progression from compensated hypertrophy to heart failure." | 7.75 | Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure. ( Baertschi, AJ; Isidoro Tavares, N; Lerch, R; Montessuit, C; Philip-Couderc, P, 2009) |
| "Angiotensin II (Ang II) and tumour necrosis factor alpha (TNFalpha) are involved in the progression from compensated hypertrophy to heart failure." | 3.75 | Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure. ( Baertschi, AJ; Isidoro Tavares, N; Lerch, R; Montessuit, C; Philip-Couderc, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isidoro Tavares, N | 2 |
| Philip-Couderc, P | 2 |
| Baertschi, AJ | 2 |
| Lerch, R | 2 |
| Montessuit, C | 2 |
| Papageorgiou, I | 1 |
2 other studies available for diazoxide and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure.
Topics: Action Potentials; Angiotensin II; Animals; ATP-Binding Cassette Transporters; Cells, Cultured; Diaz | 2009 |
Expression and function of ATP-dependent potassium channels in late post-infarction remodeling.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Diazoxide; Electric Capacitance; Gene Expression | 2007 |